Capital Group Private Client Services, Inc. Astrazeneca PLC Transaction History

Capital Group Private Client Services, Inc.

$9.55 Billion
Q1 2025

A detailed history of Capital Group Private Client Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 320,065 shares of AZN stock, worth $23.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

320,065

Previous 453,631 29.44%

Holding current value

$23.4 Million

Previous $29.7 Million 20.85%

% of portfolio

0.25%

Previous 0.29%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$65.37 - $77.96 $8.73 Million - $10.4 Million	-133,566 Reduced 29.44%	320,065 $23.5 Million
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $1.97 Million - $2.48 Million	-31,132 Reduced 6.42%	453,631 $29.7 Million
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $807,565 - $922,901	-10,533 Reduced 2.13%	484,763 $37.8 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $2.6 Million - $3.15 Million	-38,946 Reduced 7.29%	495,296 $38.6 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $2.97 Million - $3.39 Million	-48,666 Reduced 8.35%	534,242 $36.2 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $5.49 Million - $6.14 Million	-88,668 Reduced 13.2%	582,908 $39.3 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $320,359 - $354,198	-4,940 Reduced 0.73%	671,576 $45.5 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $335,917 - $364,267	-4,805 Reduced 0.71%	676,516 $48.4 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $239,275 - $271,292	-3,789 Reduced 0.55%	681,321 $47.3 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $178,079 - $231,395	3,285 Added 0.48%	685,110 $46.5 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $509,893 - $1.31 Million	-9,617 Reduced 1.39%	681,825 $37.4 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2.46 Million - $2.95 Million	41,459 Added 6.38%	691,442 $45.7 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $574,473 - $692,007	10,310 Added 1.61%	649,983 $43.1 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $654,290 - $773,108	-12,112 Reduced 1.86%	639,673 $37.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $36.2 Million - $39.6 Million	651,785 New	651,785 $39.1 Million

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $226B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Account

Capital Group Private Client Services, Inc. Astrazeneca PLC Transaction History